The United States has an ongoing behavioral health crisis marked by high rates of mental health and substance use disorders and resulting access challenges.
The Mental Health Parity and Addiction Equity Act (MHPAEA) requires health plans and insurers to offer mental health coverage in “parity” with a plan’s medical or surgical coverage.
In recent years, drug-related overdoses have become a leading cause of death during pregnancy and the postpartum period, exacerbating a mounting maternal mortality crisis and underscoring the need for improved access to care for pregnant and...
In a new webinar with frontline clinicians and policymakers, the AMA and Manatt Health will discuss the recommendations in depth and highlight state- and community-based best practices.
Last week, the Department of Health and Human Services (HHS) released a final rule intended to implement a 2020 modification to the federal substance use disorder (SUD) privacy statute.
On December 12, 2023, the MAPS Public Benefit Corporation (MAPS PBC) announced the submission of a marketing application to the U.S. Food and Drug Administration (FDA) for MDMA (midomafetamine capsules) in combination with psychological...
In recent years, an unprecedented level of interest in the promise of psychedelics has taken hold.
The Mental Health Parity and Addiction Equity Act (MHPAEA) requires health plans to provide mental health benefits, including coverage for substance use disorders (SUDs), that are in “parity” with medical and surgical benefits. The...
On July 31, 2023, the Centers for Medicare & Medicaid Services (CMS) announced a new eight-year voluntary nationwide model – the Guiding an Improved Dementia Experience (GUIDE) Model that aims to support people living with dementia and...
Last week, a Ninth Circuit panel vacated its prior decision in the long-running Wit v. United Behavioral Health litigation and issued a new opinion.